Bruno Pougault: The Thin Line Between Bleeding and Clotting
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared on LinkedIn:
“Precision in Hemostasis: The Thin Line Between Bleeding and Clotting
Behind every safe surgery, successful cancer treatment, or managed cardiovascular disease lies a critical, yet often unseen hero: the Hemostasis Laboratory.
In clinical practice, the stakes couldn’t be higher. A fraction of a second in clotting time or a slight variation in factor levels makes the difference between a catastrophic hemorrhage and a fatal thrombotic event.
Yet, the clinical value of hemostasis diagnostics depends entirely on uncompromising analytical quality and global standardization.
Swipe through the carousel below to discover why high-quality medical diagnostics are our strongest shield against hemorrhagic and thrombotic risks.
Key Highlights Inside:
- The Power of Plasma: Why plasma analysis remains the gold standard for accuracy, reproducibility, and avoiding cellular interference compared to whole blood.
- The Standardization Challenge: The critical clinical need for international harmonization in assays like D-Dimer to ensure reliable patient stratification globally.
- Risk Prevention: How robust central lab data empowers clinicians to make safer, personalized therapeutic decisions before complications arise.
In the era of modern medicine, diagnostic excellence isn’t just about running tests—it’s about ensuring absolute reliability when patients’ lives are on the line.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week